A clinical trial conducted with nine immunosuppressed DMD patients to test a protocol including a high density of injection trajectories in skeletal muscles indicated that the transplanted cultured myoblasts from one of the patient’s parent permitted the expression of the donor dystrophin in 3.5 and up to 26% of the muscle fibers in eight patients (108). This evidence concerns the gene DMD and Duchenne muscular dystrophy.